One of the first human studies on how mitochondrial function impacts immune cells to guide future treatments.

Technological breakthroughs in new modalities will be a key driver of growth for the biopharma industry over the next decade.

The FDA today approved a new therapy for early Alzheimer's disease that appears to modestly slow the progression of the disease that affects more than 6.5 million Americans.

WHO has added a fourth test to the list of prequalified tests for human papillomavirus (HPV). Although most HPV infections clear up on their own, some high-risk types could lead to cervical cancer.

SAN DIEGO — Coadministration of the long-acting amylin analog cagrilintide plus the glucagon-like peptide-1 (GLP-1) agonist semaglutide

Redness and breakouts on your face could mean that you have acne, but not always. A skin condition called rosacea can cause acne-like breakouts and redness.

SAN DIEGO – Orforglipron, Eli Lilly's investigational oral daily nonpeptide glucagon-like peptide-1 (GLP-1) agonist that can be taken with or without food, appears comparable with other injectable ...

The World Health Organization (WHO) has published the first in a series of WHO public-benefit target product profiles (TPPs) ...

Severe infections caused by group A streptococcus bacteria are on the rise in countries around the world, including the United States, according to new data from the CDC.